Pieter Koolwijk

View Scopus Profile

Research activity per year

specialisation

Stopped doing research. Entirely focused on education.

Keywords

QP Physiology

1 Active

Lecturer at the VU University of Amsterdam
Koolwijk, P.
1/01/2021 → 1/01/2028
Project: Other

62 Article
2 Review article
1 Chapter
1 Meeting Abstract
More
- 1 Comment/Letter to the editor

Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction
Juni, R. P., Al-Shama, R., Kuster, D. W. D., van der Velden, J., Hamer, H. M., Vervloet, M. G., Eringa, E. C., Koolwijk, P. & van Hinsbergh, V. W. M., May 2021, In: Kidney International. 99, 5, p. 1088-1101 14 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

32 Citations (Scopus)
Collaboration around rare bone diseases leads to the unique organizational incentive of the Amsterdam Bone Center
Eekhoff, E. M. W., Micha, D., Forouzanfar, T., de Vries, T. J., Netelenbos, J. C., Klein-Nulend, J., van Loon, J. J. W. A., Lubbers, W. D., Schwarte, L., Schober, P., Raijmakers, P. G. H. M., Teunissen, B. P., de Graaf, P., Lammertsma, A. A., Yaqub, M. M., Botman, E., Treurniet, S., Smilde, B. J., Bökenkamp, A., Boonstra, A., & 33 othersKamp, O., Nieuwenhuijzen, J. A., Visser, M. C., Baayen, H. J. C., Dahele, M., Eeckhout, G. A. M., Goderie, T. P. M., Smits, C., Gilijamse, M., Karagozoglu, K. H., van de Valk, P., Dickhoff, C., Moll, A. C., Verbraak, F. F. D., Curro-Tafili, K. K. R., Ghyczy, E. A. E., Rustemeyer, T., Saeed, P., Maugeri, A., Pals, G., Ridwan-Pramana, A., Pekel, E., Lems, W., Winters, H. A. H., Botman, M., Giannakópoulos, G. F., Koolwijk, P., Smit, J. M., Helder, M. N., Janssen, J. J. W. M., Kloen, P., Bravenboer, N. & Janssen, J. M. W. M., 11 Aug 2020, In: Frontiers in Endocrinology. 11, 7 p., 481.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

3 Citations (Scopus)
Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
Juni, R. P., Kuster, D. W. D., Goebel, M., Helmes, M., Musters, R. J. P., van der Velden, J., Koolwijk, P., Paulus, W. J. & van Hinsbergh, V. W. M., 1 Sept 2019, In: JACC. Basic to translational science. 4, 5, p. 575-591
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

131 Citations (Scopus)
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells
Sánchez-Duffhues, G., Williams, E., Benderitter, P., Orlova, V., van Wijhe, M., Garcia de Vinuesa, A., Kerr, G., Caradec, J., Lodder, K., de Boer, H. C., Goumans, M-J., Eekhoff, E. M. W., Morales-Piga, A., Bachiller-Corral, J., Koolwijk, P., Bullock, A. N., Hoflack, J. & Ten Dijke, P., 1 Nov 2019, In: JBMR Plus. 3, 11, e10230.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

24 Citations (Scopus)
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells
Uthman, L., Homayr, A., Juni, R. P., Spin, E. L., Kerindongo, R., Boomsma, M., Hollmann, M. W., Preckel, B., Koolwijk, P., van Hinsbergh, V. W. M., Zuurbier, C. J., Albrecht, M. & Weber, N. C., 2019, In: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 53, 5, p. 865-886
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

124 Citations (Scopus)

Supplementary Material for: Expression, Regulation and Function of Human Metallothioneins in Endothelial Cells
Koolwijk, P. (Contributor), Schulkens, I. A. (Contributor), Griffioen, A. W. (Contributor), Thijssen, V. L. (Contributor), Castricum, K. C. M. (Contributor) & Weijers, E. M. (Contributor), figshare Academic Research System, 1 Jan 2014
DOI: 10.6084/m9.figshare.5126842.v1, https://doi.org/10.6084%2Fm9.figshare.5126842.v1
Dataset

Pieter Koolwijk

Personal profile

specialisation

Keywords

Collaborations and top research areas from the last five years

Dive into details

Lecturer at the VU University of Amsterdam

Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction

Collaboration around rare bone diseases leads to the unique organizational incentive of the Amsterdam Bone Center

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells

Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Supplementary Material for: Expression, Regulation and Function of Human Metallothioneins in Endothelial Cells

Pieter Koolwijk

Personal profile

specialisation

Keywords

Collaborations and top research areas from the last five years

Projects

Lecturer at the VU University of Amsterdam

Research output

Empagliflozin restores chronic kidney disease-induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction

Collaboration around rare bone diseases leads to the unique organizational incentive of the Amsterdam Bone Center

Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells

Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Datasets

Supplementary Material for: Expression, Regulation and Function of Human Metallothioneins in Endothelial Cells